The analysis of 11 weight-loss drug studies by the University of Oxford found that patients typically lost 8kg (18lb) after ...

Novo Nordisk A/S' Q1 earnings reveal strong growth in semaglutide-driven sales despite a slight revenue miss. Learn more ...

It's been explained what happens if you take just one dose of Ozempic and how long the treatment stays in your system.

Oral semaglutide demonstrated superior cardiometabolic outcomes relative to placebo and active comparators, including empaglifozin, in T2D.

Here is what can happen to the body once you finish a course of Ozempic as a simulation reveals what the diabetes drug does ...

Q1 2025 Earnings Call Transcript May 13, 2025Fractyl Health, Inc. Common Stock reports earnings inline with expectations.

Q1 2025 Earnings Conference Call May 13, 2025 4:30 PM ETCompany ParticipantsBrian Luque - Head of Investor Relations ...

New research presented at the European Congress on Obesity (ECO 2025) and published in the journal Diabetes, Obesity and ...

Tirzepatide was associated with better glycemic control and weight loss outcomes than semaglutide and insulin among patients with T2D.

Hims & Hers Health ( HIMS) shares surged 8% Tuesday, a day after the health and wellness platform posted better-than-expected ...

It changed the way we diet, but now Weight Watchers’ fortunes seem to be fading. Katie Rosseinsky explores how the Ozempic ...

Semaglutide - known under brand names Ozempic ... which are made by some US pharmacies when the original drug is in short supply. These have become more common as patients look for cheaper ...